Andersen Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
The KCNJ2 gene has been identified as the causative gene of ATS.
|
31669729 |
2019 |
Andersen Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Multivariate analysis of TU wave complex on electrocardiogram in Andersen-Tawil syndrome with KCNJ2 mutations.
|
31724784 |
2019 |
Andersen Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Four different CACNA1S missense mutations were detected in hypokalemic periodic paralysis and five KCNJ2 missense mutations in Andersen-Tawil syndrome.
|
29606556 |
2018 |
Andersen Syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Gene-Targeted Analysis of Clinically Diagnosed Long QT Russian Families.
|
28003625 |
2017 |
Andersen Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
TRPM4 enlarges the subgroup of LQT genes (KCNJ2 in Andersen syndrome and CACNA1C in Timothy syndrome) known to increase the QT interval through a more complex pleiotropic effect than merely action potential alteration.
|
28315637 |
2017 |
Andersen Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Andersen-Tawil syndrome (ATS) is rare channelopathy caused by KCNJ2 mutation and probably KCNJ5.
|
28336205 |
2017 |
Andersen Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Characterization of a novel KCNJ2 sequence variant detected in Andersen-Tawil syndrome patients.
|
29017447 |
2017 |
Andersen Syndrome
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Current topics in catecholaminergic polymorphic ventricular tachycardia.
|
27761157 |
2016 |
Andersen Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Direct sequencing of KCNJ2 was performed in 12 subjects from mainland China with suspected ATS.
|
27145478 |
2016 |
Andersen Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Andersen-Tawil Syndrome (ATS) is a channelopathy caused by mutations in KCNJ2 gene.
|
26109178 |
2016 |
Andersen Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Andersen-Tawil syndrome (ATS) is caused by mutations in KCNJ2 (Kir2.1).
|
27789106 |
2016 |
Andersen Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In this study, we describe the identification and functional analysis of a novel KCNJ2 mutation, Val302del, identified in a patient with ATS.
|
26103554 |
2015 |
Andersen Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
We performed genetic analysis of KCNJ2 in 32 ATS probands and their family members and identified KCNJ2 mutations in 25 probands, 20 families who underwent extensive genetic testing.
|
24635491 |
2015 |
Andersen Syndrome
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual IK1.
|
25691870 |
2015 |
Andersen Syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Andersen-Tawil syndrome: report of 3 novel mutations and high risk of symptomatic cardiac involvement.
|
24861851 |
2015 |
Andersen Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We evaluated the efficacy and safety of flecainide for VAs in patients with ATS with KCNJ2 mutations.
|
25496985 |
2015 |
Andersen Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Andersen-Tawil syndrome is caused in a majority of cases by mutations in KCNJ2, which encodes the Kir2.1 subunit of the inwardly rectifying potassium channel.
|
24574546 |
2014 |
Andersen Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We report the first patient diagnosed with ATS with a de novo c.G899C mutation in the KCNJ2 gene in 2010 who developed an autoimmune hyperthyroidism and TPP in 2013.
|
24849934 |
2014 |
Andersen Syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Andersen-Tawil syndrome with early fixed myopathy.
|
25415519 |
2014 |
Andersen Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Our aim was to describe the clinical course of ATS in a family, in which the proband survived aborted cardiac arrest (ACA) and genetic screening revealed a previously unknown mutation (c.271_282del12[p.Ala91_Leu94del]) in the KCNJ2 gene.
|
24047492 |
2013 |
Andersen Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The loss-of-function mutations in KCNJ2 in ATS1 affect the excitability of both skeletal and cardiac muscle, which underlies the cardiac arrhythmias and periodic paralysis associated with ATS.
|
24383070 |
2013 |
Andersen Syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
|
23867365 |
2013 |
Andersen Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Non dominant-negative KCNJ2 gene mutations leading to Andersen-Tawil syndrome with an isolated cardiac phenotype.
|
23644778 |
2013 |
Andersen Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In the whole sample (665 patients), 15 out of 104 different CLCN1 mutations accounted for 60% of all patients with myotonia congenita, 11 out of 22 SCN4A mutations for 86% of paramyotonia congenita/sodium channel myotonia pedigrees, and 3 out of 17 KCNJ2 mutations for 42% of ATS pedigrees.
|
23516313 |
2013 |
Andersen Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Loss of function mutations of KCNJ2 encoding Kir2.1 result in Andersen-Tawil syndrome, a disorder characterized by periodic paralysis, cardiac arrhythmia, and dysmorphic features.
|
23188060 |
2013 |